Trademark: 88261029
Word
E2E PLATFORM
Status
Dead
Status Code
602
Status Date
Tuesday, June 2, 2020
Serial Number
88261029
Mark Type
4000
Filing Date
Monday, January 14, 2019
Abandoned Date
Monday, April 13, 2020

Trademark Owner History

Classifications
35 Business consulting and management in the field of clinical trials, namely, clinical data and regulatory submission management on behalf of medical, biopharmaceutical and biotechnology companies to assist them with clinical research, clinical trials and applications for drug approval; Business consulting and management in the field of clinical trials, namely, management and compilation of computerized databases in the field of clinical trials for business purposes; Business consulting and management in the field of clinical trials, namely, providing information management services
42 Software as a service (SAAS) services, namely, hosting software for use by others for use on behalf of medical, pharmaceutical and biotechnology companies to assist them with clinical research, clinical trials and applications for drug approval; Conducting clinical trials for others; Medical and scientific research, namely, conducting clinical trials for others
END TO END PLATFORM

Trademark Events
Jun 2, 2020
Abandonment Notice E-Mailed - Failure To Respond
Jun 2, 2020
Abandonment - Failure To Respond Or Late Response
Oct 10, 2019
Notification Of Final Refusal Emailed
Oct 10, 2019
Final Refusal E-Mailed
Oct 10, 2019
Final Refusal Written
Sep 30, 2019
Teas/Email Correspondence Entered
Sep 27, 2019
Correspondence Received In Law Office
Sep 27, 2019
Teas Response To Office Action Received
Sep 20, 2019
Attorney/Dom.Rep.Revoked And/Or Appointed
Sep 20, 2019
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Mar 27, 2019
Notification Of Non-Final Action E-Mailed
Mar 27, 2019
Non-Final Action E-Mailed
Mar 27, 2019
Non-Final Action Written
Mar 27, 2019
Assigned To Examiner
Feb 5, 2019
New Application Office Supplied Data Entered In Tram
Jan 17, 2019
New Application Entered In Tram

Trademark Alertz updated from USPTO on 2030-01-24